Aducanumab does not appear to be effective at treating adults with early-stage symptoms, the EMA said.
Alzheimer's charities say they are disappointed by the decision because thousands of people are left with no treatment options. BBC News
Monday, 20 December 2021
Alzheimer's drug aducanumab not approved for use in EU
Alzheimer's drug aducanumab not approved for use in EU The European Medicines Agency has said no to approving a new drug for Alzheimer's disease in the EU.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment